Fingolimod SLNs: Preparation, in vitro evaluation and Optimization of lyophilization using D-Optimal Experimental Design

Authors

  • Mohaddeseh Dashti nejad pour 1Department of Pharmaceutical Chemistry, Pharmaceutical Sciences Branch, Islamic Azad University (IAUPS), Tehran, Iran.
  • Mohammad Reza Khoshayand 5Department of Drug and Food Control, Faculty of Pharmacy, Tehran University of Medical Sciences, Tehran, Iran
  • SOLMAZ GHAFFARI Department of Pharmaceutics, Pharmacy Faculty, Islamic Azad University, Tehran, Iran
Abstract:

Abstract Multiple Sclerosis (MS) is one of the most common neurological disorders diagnosed in young adults. there are no current cures for the disease or its underlying causes, some drugs have been developed that can decrease or delay disease progression. Fingolimod is an immunomodulating drug, mostly used for treating multiple sclerosis (MS). It approximately halves the rate of relapse in relapsing-remitting multiple sclerosis over a two-year period; however, Fingolimod causes a number of off-target effects including cardiovascular complaints. A different delivery method may alleviate some of these effects. Lipid-based nanoparticles containing Fingolimod were prepared using cholesterol as a biocompatible lipid through a high pressure homogenization technique. The physical and chemical properties of the resulting particles, including particle size, zeta potential, morphology, drug-loading capacity and release profile, were investigated. A preferred formula was lyophilized using mannitol as the cryoprotectant. A D-optimal model was used to determine optimum freeze-drying conditions that minimized size enlargement and maximized the zeta potential of the processed particles. Results: The optimized Fingolimod SLNs are 150 nm in diameter with a Zeta potential of 19 mV. AFM imaging confirms that the particles remain spherical. Fingolimid loading efficiency was found to be 89%, and 85% of the loaded drug was released over 16 days. Results demonstrated that nanotechnology could help to prolong the drug efficacy duration as well could increase compliance of patient to continue MS control, whole life duration. Conclusion: Sustained release Fingolimod SLNs using cholesterol as the matrix are effective and may provide an alternative to oral drug administration to prolong drug administering intervals and increase chance of treatment following by patients.

Upgrade to premium to download articles

Sign up to access the full text

Already have an account?login

similar resources

Formulation and Optimization of Captopril Sublingual Tablet Using D-Optimal Design Sublingual Tablet Using D-Optimal Design

The objective of the current study was to develop and optimize a sublingual tablet formulation of captopril which is an effective drug in the treatment of hypertension. Captopril containing tablets were prepared by direct compression method using different ingredients such as polyvinyl pyrrolidone, starch 1500, sodium starch glycolate and lactose (independent variables) and magnesium stearate, ...

full text

Formulation and Optimization of Captopril Sublingual Tablet Using D-Optimal Design Sublingual Tablet Using D-Optimal Design

The objective of the current study was to develop and optimize a sublingual tablet formulation of captopril which is an effective drug in the treatment of hypertension. Captopril containing tablets were prepared by direct compression method using different ingredients such as polyvinyl pyrrolidone, starch 1500, sodium starch glycolate and lactose (independent variables) and magnesium stearate, ...

full text

Preparation and In-vitro Evaluation of Rifampin-loaded Mesoporous Silica Nanoaggregates by an Experimental Design

The goal of this research is preparation, optimization and in-vitro evaluation of rifampin-loaded silica nanaoparticles in order to use in pulmonary drug delivery. Nanoparticles are exhaled because of thier small size, Preparation of nanoaggregates in micron-sized scale and re-disrpersion of them after the deposition in the lung is one approach in order to overcome this problem, which we used i...

full text

Preparation and In-vitro Evaluation of Rifampin-loaded Mesoporous Silica Nanoaggregates by an Experimental Design

The goal of this research is preparation, optimization and in-vitro evaluation of rifampin-loaded silica nanaoparticles in order to use in pulmonary drug delivery. Nanoparticles are exhaled because of thier small size, Preparation of nanoaggregates in micron-sized scale and re-disrpersion of them after the deposition in the lung is one approach in order to overcome this problem, which we used i...

full text

formulation and optimization of captopril sublingual tablet using d-optimal design sublingual tablet using d-optimal design

the objective of the current study was to develop and optimize a sublingual tablet formulation of captopril which is an effective drug in the treatment of hypertension. captopril containing tablets were prepared by direct compression method using different ingredients such as polyvinyl pyrrolidone, starch 1500, sodium starch glycolate and lactose (independent variables) and magnesium stearate, ...

full text

Optimization of SiC particle distribution during compocasting of A356-SiCp composites using D-optimal experiment design

This paper presents an experimental design approach to the process parameter optimization for compocasting of A356-SiCp composites. Toward this end, parameters of stirring temperature, stirring time, stirring speed and SiC content were chosen and three levels of these parameters were considered. The D-optimal design of experiment (DODE) was employed for experimental design and analysis of resul...

full text

My Resources

Save resource for easier access later

Save to my library Already added to my library

{@ msg_add @}


Journal title

volume 6  issue 2

pages  119- 128

publication date 2018-09-01

By following a journal you will be notified via email when a new issue of this journal is published.

Hosted on Doprax cloud platform doprax.com

copyright © 2015-2023